CROs, convergence and commercial opportunities

How industry convergence is creating win/win opportunities for contract research and life sciences organizations.

With the Contract Research Organization (CRO) sector experiencing modest growth in recent years, many are starting to explore whether ongoing convergence in the U.S. healthcare industry may be creating opportunities for higher revenue growth. Our research suggests that significant untapped advantages may result from expanding the existing strategic relationships between CROs and their life sciences clients, and, thereby, creating new value streams.